In pre-clinical studies with rodent models, liposomal tacrolimus has shown potential efficacy in mitigating symptoms of CYP-induced cystitis [99] and holds therapeutic promise in managing radiation-induced and hemorrhagic cystitis [100]. This evidence concerns the gene PPIG and cystitis.